Hualan Biological Engineering Stock Forecast for 2023 - 2025 - 2030
Updated on 03/27/2024
Hualan Biological Engineering Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Hualan Biological Engineering were recently set by distinguished experts, with an average mark of ¥25.97. If it reached this goal, it would represent a potential upside of approximately 29.91% from the previous closing price in March, 2024. The high end is ¥30.00, and the low is ¥19.00. Even if not interested in 002007 stock, you may want to be aware of its competitors.
29.91% Upside
Hualan Biological Engineering Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Hualan Biological Engineering's Price has gone down from ¥32.66 to ¥0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will reach ¥38.30 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$43.48 | Buy/Sell | $44.86 | 3.50% |
600161 Stock Forecast | Beijing Tiantan Biological Pro... | Buy |
18
|
¥28.10 | Buy/Sell | ¥31.28 | 12.03% |
GRF Stock Forecast | Grifols | Outperform |
18
|
8.48€ | Buy/Sell | 18.48€ | 116.98% |
300294 Stock Forecast | China Resources Boya Bio-pharm... | Outperform |
16
|
¥28.23 | Buy/Sell | ¥35.07 | 21.68% |
002880 Stock Forecast | Shenzhen Weiguang Biological P... | Buy |
18
|
¥28.41 | Buy/Sell | ¥42.00 | 47.84% |
Hualan Biological Engineering Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Hualan Biological Engineering's Revenue has gone down from ¥5.02B to ¥4.52B – a 10.08% drop. In the next year, analysts predict that Revenue will reach ¥6.37B – an increase of 40.96%. For the next seven years, the forecast is for Revenue to grow by 39.90%.
Hualan Biological Engineering Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Hualan Biological Engineering's Dividend per Share has fallen from ¥0.30 to ¥0.30 – a 0.00% decrease. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach ¥0.38 – an increase of 26.67%. The Hualan Biological Engineering forecast is for Dividend per Share to reach ¥0.34 or grow by 14.29%.
Hualan Biological Engineering EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Hualan Biological Engineering's EBITDA has decreased by 31.38%, going from ¥2.18B to ¥1.50B. In the next year, analysts expect EBITDA to reach ¥2.41B – an increase of 61.14%. For the next seven years, the forecast is for EBITDA to grow by 64.52%.
Hualan Biological Engineering EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Hualan Biological Engineering's EBIT has decreased from ¥2.00B to ¥1.22B – a 38.78% drop. The next year looks promising for Hualan Biological Engineering, with analysts predicting EBIT of ¥2.26B – an increase of 84.36%. Over the next seven years, experts anticipate that Hualan Biological Engineering's EBIT will grow at a rate of 289.34%.
Hualan Biological Engineering EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Hualan Biological Engineering's EPS has gone down from ¥0.81 to ¥0.00 – a 100.00% drop. In the next year, analysts predict that EPS will reach ¥0.95 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.